IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis. (2020)

First Author: Catapano M
Attributed to:  Optimising therapeutic strategy in psoriasis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2019.08.444

PubMed Identifier: 31539532

Publication URI: http://europepmc.org/abstract/MED/31539532

Type: Journal Article/Review

Volume: 140

Parent Publication: The Journal of investigative dermatology

Issue: 4

ISSN: 0022-202X